What is LOPJLB’s current signal on NBTX?

LOPJLB’s latest quantitative signal on Nanobiotix S.A. (NBTX) is BUY in a CRISIS regime. Signals are updated daily.

What market regime is NBTX in?

Nanobiotix S.A. (NBTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Nanobiotix S.A. (NBTX) do?

Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising crystalline hafnium oxide nanoparticles. This treatment is currently undergoing development for its potential application in a broad spectrum of cancers, including soft tissue sarcoma…

Where is Nanobiotix S.A. based / listed?

Nanobiotix S.A. is based in FR, listed on NASDAQ.

Nanobiotix S.A. (NBTX)

Healthcare · Biotechnology · NASDAQ · FR

$39.66-8.93%Close

BUYCRISIS · day 1

[SCORES & PROFILE]

FUND: 6
VALUE: 10
GROWTH: 8
GARP: 5
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC18.7%

REV YoY-

ROE31.2%

EPS YoY-

ROA-35.4%

GROSS

100

-36

NET

-81

[VALUATION]

P/E TTM-66.94

P/E FWD-

SECTOR PE22.66

INDUSTRY PE17.07

P/B-19.16

P/FCF-

EV/EBITDA-147.25

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO1.09

ND/EBITDA-

BETA0.57

Nanobiotix S.A. (NBTX)

Key stats

Sector peers

Industry peers

Prediction markets

FUNDAMENTALS

Company news